Attruby Side Effects
Generic name: acoramidis
Medically reviewed by Drugs.com. Last updated on May 10, 2025.
Note: This document provides detailed information about Attruby.
Applies to acoramidis: oral tablets Side Effects associated with acoramidis. Some dosage forms listed on this page may not apply specifically to the brand name Attruby.
Applies to acoramidis: oral tablets.
Side effects include:
Diarrhea and upper abdominal pain.
For healthcare professionals
Applies to acoramidis: oral tablet.
General adverse events
The most frequent adverse events were gastrointestinal adverse reactions such as diarrhea and upper abdominal pain.[Ref]
Gastrointestinal
- Very common (10% or more): Diarrhea (11.6%)
- Common (1% to 10%): Upper abdominal pain[Ref]
Renal
- Frequency not reported: Increased serum creatinine, decreased estimated glomerular filtration rate[Ref]
See also:
Vyndamax
Vyndamax may be given to reduce death or hospitalization caused by heart problems in adults with ...
Amvuttra
Amvuttra is used to treat polyneuropathy associated with hereditary transthyretin-mediated ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Vyndaqel
Vyndaqel (tafamidis meglumine) is a transthyretin stabilizer that may be given to reduce death or ...
Vutrisiran
Vutrisiran is used to treat adults with nerve damage (polyneuropathy) caused by hereditary ...
References
1. (2024) "Product Information. Attruby (acoramidis)." BridgeBio Pharma, Inc
More about Attruby (acoramidis)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: transthyretin stabilizers
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Attruby side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.